Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 31;2021:9494619. doi: 10.1155/2021/9494619

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Yunkun Yan et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Relationship between PCAT14 expression and clinically relevant indicators in prostate cancer. (a) Compared with T2 stage prostate cancer, PCAT14 was lowly expressed in T3-4 stage prostate cancer tissues. (b) Compared with N0 stage prostate cancer, PCAT14 was lowly expressed in N1 stage prostate cancer tissues. (c) Compared with M0 stage prostate cancer, PCAT14 was lowly expressed in M1 stage prostate cancer tissue. (d) Compared with the prostate cancer group with Gleason score = 6-7, PCAT14 was lowly expressed in prostate cancer tissue with Gleason score = 8-10. (e) PCAT14 was lowly expressed in prostate cancer tissues with the initial treatment outcome of progressive disease, stable disease, and partial response compared with prostate cancer tissues with initial treatment outcome of complete response. (f) PCAT14 was lowly expressed in R1&2 prostate cancer tissue compared with prostate cancer in R0 prostate cancer tissue.